/OACC

OACC Stock - Oaktree Acquisition Corp. III Life Sciences

Q: What is the analyst price target for OACC?

Analyst price target information is not currently available for OACC.

Q: What is OACC's market cap?

Market capitalization information is not currently available for OACC.

Financial Services|Shell Companies|NASDAQ

$10.63-0.11%

$0.01 (-0.11%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $11.69

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for OACC

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2024

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-0.12

52W High$10.85

52W Low$9.95

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2024
Revenue	N/A
Gross Profit	N/A
Gross Margin	N/A
Operating Income	$-703
Net Income	$2,663
Net Margin	N/A
EPS	$0.05

Company Overview

Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.

Visit Website

Frequently Asked Questions about OACC

What is OACC's current stock price?

Oaktree Acquisition Corp. III Life Sciences (OACC) is currently trading at $10.63 per share. The stock has moved -0.11% today.

What is the analyst price target for OACC?

No analyst price targets are currently available for this stock.

What sector is Oaktree Acquisition Corp. III Life Sciences in?

Oaktree Acquisition Corp. III Life Sciences operates in the Financial Services sector, specifically within the Shell Companies industry. The company is traded on the NASDAQ exchange.

What is OACC's market cap?

Oaktree Acquisition Corp. III Life Sciences has a market capitalization of $0.26 billion, making it a small-cap company.

Does OACC pay dividends?

No, Oaktree Acquisition Corp. III Life Sciences does not currently pay a dividend to shareholders.